SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice



Wilding, John ORCID: 0000-0003-2839-8404, Fernando, Kevin, Milne, Nicola, Evans, Marc, Ali, Amar, Bain, Steve, Hicks, Debbie, James, June, Newland-Jones, Philip, Patel, Dipesh
et al (show 1 more authors) (2018) SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice. DIABETES THERAPY, 9 (5). 1757 - 1773.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: Clinical guidance, Glucose-lowering medicines, Oral glucose-lowering medicines, Prescribing tools, Risk/benefit, SGLT2 inhibitors, Therapy choice, Type 2 diabetes
Depositing User: Symplectic Admin
Date Deposited: 14 Nov 2018 09:18
Last Modified: 15 Oct 2021 13:10
DOI: 10.1007/s13300-018-0471-8
Open Access URL: https://link.springer.com/article/10.1007/s13300-0...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3028766